focus -WSS

focus

author：leisure time 2025-09-27 12:56:52 - browse：1

novavax photo illo — JUSTIN TALLIS/AFP via Getty Images

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, all. Damian here with an update on the plight of the other Covid-19 vaccine company, Wall Street’s latest GLP-1 trade, and the quest for a universal antivenom.

The need-to-know this morning

Ocular Therapeutics announced a shakeup of its senior management team and a $325 million private placement.
Amylyx Therapeutics said results from a closely followed Phase 3 study of its treatment for ALS could come before the start of the second quarter — earlier than previously expected.
Moderna earnings are here.

Novavax’s money is going in the wrong direction

The good news for Novavax is that it’s no longer facing a $700 million dispute with a global charity organization. The bad news is that settling that dispute will force the struggling company to pay out $400 million over the next five years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Focused ultrasound for uterine fibroids: an uphill battle

entertainment

WSS

Solve the antibiotic resistance crisis with preventive drugs

Akili, maker of video game for ADHD, to be acquired for 34 million

Startling documents reveal new facets of Sacklers' opioid empire

Hospital price transparency does save money, advocate argues

Medicare reduced heart disease by changing how it pays doctors

STAT Summit: GSK CEO on pharma giant's new direction

Wikipedia

focus

The need-to-know this morning

Novavax’s money is going in the wrong direction

focus

Psychedelics group wrestles with new pharma identity

Scientists successfully use ultrasound imaging to map brain activity

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

What does generative AI mean for health care? We asked experts

STAT Summit: Michael J. Fox on progress in Parkinson's research

Supreme Court strikes down use of affirmative action

How climate

Drug repurposing or repositioning? The language matters

iTeos Therapeutics debuts first data on TIGIT

explore

FDA gives detailed accounting of AI

Report: NIH

Dark money group runs ads on China biotech bill

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Focused ultrasound for uterine fibroids: an uphill battle

Biohaven protein

focus

focus

entertainment

focus